BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11571894)

  • 21. Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jun; 66(112):31146-65. PubMed ID: 11725786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions.
    JAMA; 1995 Nov; 274(17):1374-9. PubMed ID: 7563563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion-related AIDS litigation: permitting limited discovery from blood donors in single donor cases.
    Kunin PB
    Cornell Law Rev; 1991 May; 76(4):927-61. PubMed ID: 10111164
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimising the safety of blood products.
    Pauli G
    Infusionsther Transfusionsmed; 1996 Jun; 23(3):122-3. PubMed ID: 8782707
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-awaited Canadian blood report released.
    Murray T
    Nat Med; 1998 Jan; 4(1):10. PubMed ID: 9427591
    [No Abstract]   [Full Text] [Related]  

  • 26. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting Factor VIII cases: is it time for an agency adjudication system?
    Su YC
    Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis C virus infection in blood donors: to screen or not to screen?
    Anand AC; Dhot PS; Ohri VC
    Natl Med J India; 1997; 10(6):304-5. PubMed ID: 9481109
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood bank trade group held liable for HIV-tainted transfusion.
    AIDS Policy Law; 1996 Jun; 11(12):1, 10-1. PubMed ID: 11363570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oversight and monitoring of blood safety in the United States.
    Busch M; Chamberland M; Epstein J; Kleinman S; Khabbaz R; Nemo G
    Vox Sang; 1999; 77(2):67-76. PubMed ID: 10516550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of the blood supply.
    Sloand EM; Pitt E; Klein HG
    JAMA; 1995 Nov; 274(17):1368-73. PubMed ID: 7563562
    [No Abstract]   [Full Text] [Related]  

  • 32. Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s.
    Weinberg PD; Hounshell J; Sherman LA; Godwin J; Ali S; Tomori C; Bennett CL
    Ann Intern Med; 2002 Feb; 136(4):312-9. PubMed ID: 11848729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential liability for transfusion-associated AIDS.
    Miller PJ; O'Connell J; Leipold A; Wenzel RP
    JAMA; 1985 Jun; 253(23):3419-24. PubMed ID: 3889395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Product liability. Fault lines.
    Wilder G
    Health Serv J; 2001 Jun; 111(5760):suppl 12. PubMed ID: 11436764
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; RomanĂ² L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transfusion safety, time for a new partnership between stake-holders].
    Erard AC; Garnerin P; Michel M; Peyrard T; Clergue F
    Rev Med Suisse; 2006 Nov; 2(88):2680-3. PubMed ID: 17265807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings of a consensus conference: Risk-Based Decision Making for Blood Safety.
    Leach Bennett J; Blajchman MA; Delage G; Fearon M; Devine D
    Transfus Med Rev; 2011 Oct; 25(4):267-92. PubMed ID: 21763103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV and the blood supply: an analysis of crisis decision making. Executive summary. The Institute of Medicine, National Academy of Sciences Committee to Study HIV Transmission Through Blood and Blood Products.
    Leveton LB; Sox HC; Stoto MA
    Transfusion; 1996 Oct; 36(10):919-27. PubMed ID: 8863781
    [No Abstract]   [Full Text] [Related]  

  • 39. Japan compensates some of its hepatitis C victims.
    McCurry J
    Lancet; 2008 Mar; 371(9618):1061-2. PubMed ID: 18380033
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk management in blood transfusion services.
    Whyte G
    Vox Sang; 1998; 74 Suppl 2():105-9. PubMed ID: 9704431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.